Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytotoxic triterpenoids from Maytenus retusa.
Oramas-Royo SM, Chávez H, Martín-Rodíguez P, Fernández-Pérez L, Ravelo AG, Estévez-Braun A. Oramas-Royo SM, et al. J Nat Prod. 2010 Dec 27;73(12):2029-34. doi: 10.1021/np100517u. Epub 2010 Nov 23. J Nat Prod. 2010. PMID: 21090801
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Oncotarget. 2017 May 2;8(18):29679-29698. doi: 10.18632/oncotarget.11425. Oncotarget. 2017. PMID: 27557509 Free PMC article.
5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation.
Quintana-Espinoza P, Martín-Acosta P, Amesty Á, Martín-Rodríguez P, Lorenzo-Castrillejo I, Fernández-Pérez L, Machín F, Estévez-Braun A. Quintana-Espinoza P, et al. Bioorg Med Chem. 2017 Mar 15;25(6):1976-1983. doi: 10.1016/j.bmc.2017.02.024. Epub 2017 Feb 13. Bioorg Med Chem. 2017. PMID: 28233678
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Guerra B, Martín-Rodríguez P, Díaz-Chico JC, McNaughton-Smith G, Jiménez-Alonso S, Hueso-Falcón I, Montero JC, Blanco R, León J, Rodríguez-González G, Estévez-Braun A, Pandiella A, Díaz-Chico BN, Fernández-Pérez L. Guerra B, et al. Oncotarget. 2018 Aug 14;9(63):32272. doi: 10.18632/oncotarget.26008. eCollection 2018 Aug 14. Oncotarget. 2018. PMID: 30181817 Free PMC article.
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
Martín-Rodríguez P, Guerra B, Hueso-Falcón I, Aranda-Tavío H, Díaz-Chico J, Quintana J, Estévez F, Díaz-Chico B, Amesty A, Estévez-Braun A, Fernández-Pérez L. Martín-Rodríguez P, et al. Front Pharmacol. 2019 Jan 9;9:1546. doi: 10.3389/fphar.2018.01546. eCollection 2018. Front Pharmacol. 2019. PMID: 30687103 Free PMC article.
89 results